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Abstract
While quick diagnosis units (QDUs) have expanded as an innovative cost-effective alternative to admission for workup, studies
investigating how QDUs compare are lacking. This study aimed to comparatively describe the diagnostic performance of the QDU of
an urban district hospital and the QDU of its reference general hospital.
This was an observational descriptive study of 336 consecutive outpatients aged ≥18 years referred to the QDU of a urban district
hospital in Barcelona (QDU1) during 2009 to 2016 for evaluation of suspected severe conditions whose physical performance
allowed them to travel from home to hospital and back for visits and examinations. For comparison purposes, 530 randomly selected
outpatients aged ≥18 years referred to the QDU of the reference tertiary hospital (QDU2), also in Barcelona, were included. Clinical
and QDU variables were analyzed and compared.
Mean age and sex were similar (61.97 (19.93) years and 55% of females in QDU1 vs 60.0 (18.81) years and 52% of females in
QDU2; P values= .14 and .10, respectively). Primary care was the main referral source in QDU1 (69%) and the emergency
department in QDU2 (59%). Predominant referral reasons in QDU1 and 2 were unintentional weight loss (UWL) (21 and 16%), anemia
(14 and 21%), adenopathies and/or palpablemasses (10 and 11%), and gastrointestinal symptoms (10 and 19%). Time-to-diagnosis
was longer in QDU1 than 2 (12 [1–28] vs 8 [4–14] days; P< .001). Malignancy was more common in QDU2 than 1 (19 vs 13%;
P= .001). Patients from both groups with malignancy, aged ≥65 years and requiring>2 visits to be diagnosed were in general more
likely to be males, to have UWL and adenopathies and/or palpable masses but less likely anemia, to undergo more examinations
except endoscopy, and to be referred onward to specialist outpatient clinics.
Despite some differences, results showed that, for diagnostic purposes, the overall performance and effectiveness of QDUs of
urban district and reference general hospitals in evaluating patients with potentially serious conditions were similar. This study, the first
to compare the performance of 2 hospital-based QDUs, adds evidence to the opportunity of producing standardized guidelines to
optimize QDUs infrastructure, functioning, and efficiency.
Abbreviations: CT = computed tomography, EDs = emergency departments, FDG-PET = fluorodeoxyglucose-positron
emission tomography, IQR = interquartile range, PCCs = primary care centers, QDUs = quick diagnosis units, QDU1 = quick
diagnosis unit of Hospital Plató, QDU2= quick diagnosis unit of Hospital Clínic, SD= standard deviation, UWL= unintentional weight
loss.
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Despite the advantages of a universal organization, public health
system has also their inherent risks. In Spain, unrestricted access
has produced overuse and abuse, with a system responding to
patient demands rather than needs.[1,2] With the arrival of the
financial crisis in 2008, many European countries with public
health systems tried to face the challenge of their viability and
sustainability with rather unpopular measures such as exclusion
from public funding of some tests and treatments without added
value and copayments.[3–5] Improvements in efficiency have also
been pursued through mergers of hospital centers, accelerating
the switch from the traditional mode focused on hospitalization
to outpatient care, and primary care interventions.[6–8] It has been
recommended to improve the quality of primary care through a
better follow-up of chronic diseases such as chronic obstructive
pulmonary disease, asthma and diabetes mellitus in order to
avoid unnecessary inpatient admissions.[9,10] Indeed, inappropri-
ate admissions are frequently used as an indicator of problems of
access to primary care.[10] Outpatient alternatives have also been
promoted to directly reducing the number of hospitalizations
and lengths of stays both for treatment (e.g., day care hospitals,
home hospitalization programs, telemedicine) and diagnostic
purposes.[8,10–14] While conventional hospitalizations for diag-
nostic workup are considered inappropriate admissions,[8,15,16]
they have been estimated to account for 15% to 20% of
inpatients in internal medicine wards of Spanish hospitals.[17,18]
An innovative cost-effective alternative to this type of admissions
was the creation of the so-called quick diagnosis units
(QDUs).[19]
The first QDU was established in the United Kingdom, at the
Queen Elizabeth Hospital in Birmingham, and was based on an
outpatient diagnostic assessment of patients with clinical
suspicion of malignancy, with guide-symptoms driving the
appropriate specialist (e.g., breast masses—gynecologists).[20]
Although inspired by the Birmingham experience, QDUs are
slightly different: they are led by general internists and are not
exclusively centered on cancer, even though suspicion of cancer
constitutes the main reason for referral to these units.[19,21,22]
Considering the reduction in the rate of admissions for workup
and the corresponding hospitalization costs from switching to
QDUs, the reported evidence relative to these units including data
about referral criteria, organization, and effectiveness is very
limited.[22–27]
While published studies are mostly from Spanish groups, the
first QDU was created in 1996 in the community Hospital of
Granollers. Its results were reported in 2004 in a Spanish medical
journal.[26] A subsequent study published in 2009 in an
international medical journal about the experience of the
Hospital of Granollers QDU and the general tertiary Hospital
Clínic of Barcelona QDU revealed a similar diagnostic effective-
ness, markedly lower costs, and greater patient satisfaction scores
compared with traditional admission for the same evaluable
disorders.[19] Although numerous QDUs have emerged during
the last 15 years in several hospitals including general tertiary
centers such as the Hospital Clinic of Barcelona and the Hospital
of Bellvitge and smaller community centers such as the Hospital
of Granollers, no study has evaluated how QDUs compare
between them. The purpose of this observational descriptive
study was to characterize the diagnostic performance of the QDU
of an urban district hospital in Barcelona in assessing patients
with potentially serious disorders and compare it with the QDU
of its reference general hospital.2
2. Materials and methods
2.1. Settings
The QDU of Hospital Plató (QDU1) was created in 2009 and is
integrated in the internal medicine department of this hospital. It
is an urban district hospital in Barcelona providing care to a
reference population of 140,000. It has 120 beds for acute
patients and the general Hospital Clínic is its reference center.
The unit evaluates patients with suspected severe conditions
whose physical performance allows them to travel from home to
hospital and back for visits and examinations. Similar to
inpatients, diagnostic tests are preferentially arranged. The
attending physician in charge of the unit is a general internist
who dedicates 4hours per week to this clinical duty. The QDU of
Hospital Clínic (QDU2) was created in 2005 and is also
integrated in the internal medicine department of this hospital
and, in particular, in an adult day-care center. It is a public
tertiary academic hospital in Barcelona with 855 beds and a
reference population of almost 550,000. Like QDU1, QDU2
evaluates patients with potentially serious diseases with a
preserved general status that allows them to undergo an
outpatient scheduled study. QDU2 staff includes a consultant
general internist full-time, a senior internal medicine resident, a
nurse part-time, a nurse coordinator part-time, and 2 secretaries
part-time. The unit is open 5hours a day, 4 days a week.2.2. Study design and population
We evaluated 336 consecutive patients aged≥18 years referred to
QDU1 between November 2009 and February 2016. For
comparative purposes, we also retrospectively analyzed 530
patients aged ≥18 years who were referred to QDU2. These
patients were chosen randomly, using a computer-generated
numbers table, from 5250 consecutive patients who were
assessed at QDU2 during the same period. All the patients were
referred to the 2 units from primary care centers (PCCs), hospital
emergency departments (EDs), outpatient clinics, and from
inpatients wards (e.g., patients admitted to evaluate a certain
condition who were prematurely discharged as they were deemed
to be suitable for study on an outpatient basis). The main referral
clinical criteria of QDU1 were the same as those of QDU2.[19,24]
Referrals were made by the hospital computerized information
system, phone calls, and emails. All the patients were scheduled at
least for the first visit. The patients lost before the first visit or
before the evaluation concluded were excluded from the study.
The working protocol of the 2 units consists of a quick first
appointment (usually within 5 days of referral) followed by
preferential programming of diagnostics tests and subsequent
visits until a diagnosis is made. For QDU1, there is an a priori
expectation of not more than 15 days between the first and the
last visit and of, ideally, up to 2 visits to make a diagnosis.
Diagnostic examinations were conducted either at the corre-
sponding hospitals or, when unavailable at Hospital Plató, at
other centers (principally its reference hospital). The diagnos-
ticians in QDU1 and 2 did not change throughout the study
period.
The study received approval by the research ethics committee
of the network of hospitals to which Hospital Plató belongs to
(CEIC—Unió Catalana d’Hospitals) and by the research ethics
committee of Hospital Clínic. All the patients from the QDU1
group provided written informed consent. Informed consent was
waived for QDU2 patients, who were retrospectively evaluated.
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Data from all the patients evaluated were recorded onto case
report forms and codified in a database. Recorded data included
sex, age, number of patients aged ≥65 years, sources of referral,
date of and clinical reason for referral, date of first QDU visit,
time to first visit (interval between referral and first visit at QDU),
number of visits, successive-to-first visit ratio, type and number of
diagnostic examinations, waitimg time to examination (interval
between QDU physician’s order and the examination being
actually performed), final diagnosis, time-to-diagnosis (interval
between first visit at QDU and final diagnosis), number of
patients needing 2 visits to achieve a diagnosis, and onward
referrals.Table 1







Age, y, mean (SD) 61.97 (19.93) 60.0 (18.81) .14
≥65 y, n (%) 175 (52) 263 (50)
<65 y, n (%) 161 (48) 267 (50)
Sex, n (%) .10
Females 185 (55) 276 (52)
Males 151 (45) 254 (48)
Referral sources, n (%)
Primary care centers 233 (69) 175 (33) <.001
Emergency departments 58 (17) 313 (59) <.001
Hospital outpatient clinics 39 (12) 32 (6) .007
Others 6 (2) 10 (2) .31
Reasons for referral, n (%)
Unintentional weight loss 71 (21) 85 (16) .02
Adenopathies and/or palpable masses 32 (10) 58 (11) .26
Anemia 46 (14) 111 (21) <.001
Fever 9 (3) 64 (12) <.001
Gastrointestinal symptomsa 32 (10) 101 (19) <.001
Test abnormalitiesb 48 (14) 27 (5) <.001
Osteoarticular symptomsc 21 (6) 11 (2) .06
Unexplained tiredness 17 (5) 5 (1) .05
Respiratory symptoms 8 (2) 32 (6) .05
Neurological disorders 7 (2) 4 (1) .30
Ascites 2 (1) 10 (2) .26
Other 43 (13) 22 (4) <.001
Time to first visit (d), median [IQR] 5 [2–8] 3 [1–5] .008
Number of visits, median [IQR] 2 [1–3] 2.5 [1.5–4] .003
Successive-to-first visit ratio 1.12 2.13 <.001
2 visits to achieve diagnosis, n (%) 246 (73) 302 (57) <.001
Time-to-diagnosis (days), median [IQR] 12 [1–28] 8 [4–14] <.001
Final diagnosis, n (%)
Malignancy 45 (13) 101 (19) .001
No malignancy 279 (83) 419 (79) .07
Lost to follow-up 12 (4) 10 (2) .15
Referral upon discharge, n (%)
Primary care centers 140 (42) 318 (60) <.001
Hospital Plató outpatient clinics 142 (42) na na
Hospital Clínic outpatient clinics 28 (8) 186 (35) <.001
Others 10 (3) 7 (1) .16
Admission 4 (1) 8 (2) .28
Lost to follow-up 12 (4) 11 (2) .19
IQR= interquartile range, na=not applicable, QDU1=quick diagnosis unit of Hospital Plató, QDU2=
quick diagnosis unit of Hospital Clínic, SD= standard deviation.
a Mostly including rectorrhagia, dysphagia, chronic diarrhea, severe constipation, and unexplained
severe abdominal pain.
b Mostly including plain X-ray abnormalities, liver function tests abnormalities, hemogram
abnormalities, and monoclonal paraprotein.
c Mostly including arthritis and bone pain.
Missing data: variable “time to first visit” (n=9 in QDU2 patients).2.4. Analysis of data
Qualitative variables were compared using the x2 test or the
Fisher exact test, as appropriate, and are expressed as absolute
frequencies (%). Quantitative variables with a normal distribu-
tion were compared using the Student t test and are expressed as
means with standard deviations (SD). The nonparametric
Mann–Whitney U test was used, when appropriate, to compare
continuous variables with skewed distributions and the results
are expressed as medians with interquartile ranges [IQR].
Statistical significance was established at .05. Analyses were
done with SPSS software (version 21.0) (SPSS, Chicago, IL).
3. Results
Table 1 shows the general characteristics of patients from the 2
groups including demographic data, referral sources, clinical
reasons for referral, time to first visit, and QDU outcomes during
the diagnostic evaluation including, among others, final diagnosis
(malignancy/no malignancy) and onward referrals. Overall, 23
patients (12 QDU1 and 11 QDU2 patients) were lost to follow-
up. Among QDU2 patients, there was a minimal rate of missing
data on the variable “time to first visit” and complete data on
other variables.
Mean age and sex were not significantly different (61.97
(19.93) years and 55% of females in QDU1 vs 60.0 (18.81) years
and 52% of females in QDU2; P values= .14 and .10,
respectively). While QDU1 patients were predominantly referred
from PCCs (69%), EDs were the main referral source of QDU2
subjects (59%). The most frequent reasons for referral to QDU1
were unintentional weight loss (UWL) (21%), tests detected at
referral sites (herein referred to as test abnormalities (mostly
laboratory and plain X-ray abnormalities)) (14%), anemia
(14%), abnormal peripheral lymphadenopathy and/or palpable
masses (10%), and gastrointestinal symptoms (10%). In QDU2,
the most common referral reasons were anemia (21%),
gastrointestinal symptoms (19%), UWL (16%), fever (12%),
and adenopathies and/or palpable masses (11%). The median
time to first visit was longer in QDU1 than in QDU2 patients (5
[2–8] vs 3 [1–5] days; P= .008) and the median number of visits
was lower in QDU1 patients (2 [1–3] vs 2.5 [1.5–4], respectively;
P= .003). The 336 first visits in QDU1 generated 375 successive
visits with a successive-to-first visit ratio of 1.12, whichwas lower
than the QDU2 ratio (2.13) (P< .001). While QDU1 patients
were more likely than QDU2 to require 2 visits to achieve a
diagnosis (73 vs 57%; P< .001), the median time-to-diagnosis
was longer in the former (12 [1–28] vs 8 [4–14] days, respectively;
P< .001). Although a final diagnosis of no malignancy prevailed
over malignancy in both QDU1 and 2 patients (83 and 79%),3
malignancy was more common among the latter (19 vs 13%,
respectively; P= .001). After diagnosis, most QDU1 patients were
referred to outpatient clinics of Hospital Plató and PCCs (42%
each), with 8% being referred to specialist outpatient clinics of
the reference Hospital Clínic. In addition, 60% of QDU2 patients
were referred onward to PCCs and 35% to the hospital
outpatient clinics (Table 1).
Table 2 shows the comparative frequency of diagnostic
examinations and waiting times to each examination in the 2
groups. At first visit, nearly all the patients underwent laboratory
tests and plain X-rays (98 and 87%, respectively, in QDU1 and
97 and 90%, respectively, in QDU2). The QDU2 patients
underwent significantly more ultrasonographies, endoscopies,
Table 2







CT scan, n (%) 95 (28) 170 (32) .07
Waiting time (d), median [IQR] 2 [1–5] 3 [1.5–4.5] .03
MRI, n (%) 28 (8) 53 (10) .14
Waiting time (d), median [IQR] 4.5 [3–9] 5 [2–7] .07
Ultrasonography, n (%) 28 (8) 80 (15) <.001
Waiting time (d), median [IQR] 3 [1–7] 2 [1–4] .04
Endoscopy, n (%) 37 (11) 90 (17) .002
Waiting time (d), median [IQR] 12 [7–27.5] 5 [2–8] <.001
Scintigraphy, n (%) 6 (2) 16 (3) .18
Waiting time (d), median [IQR] 7 [2–10.5] 2 [1–3] <.001
Body FDG-PET, n (%) 7 (2) 21 (4) .13
Waiting time (d), median [IQR] 6 [2–8] 3 [1.5–5] <.001
Cytology/biopsy, n (%) 32 (10) 111 (21) <.001
Waiting time (d), median [IQR] 3 [1–6] 4 [2–6] .03
Bone marrow aspiration, n (%) 12 (4) 37 (7) .10
Waiting time (d), median [IQR] 2 [2–5] 1.5 [1–3] .08
CT= computed tomography, FDG-PET= fluorodeoxyglucose-positron emission tomography, IQR=
interquartile range, MRI=magnetic resonance imaging, QDU1=quick diagnosis unit of Hospital Plató,
QDU2=quick diagnosis unit of Hospital Clínic.
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more, significant differences were observed in the waiting times to
computed tomography (CT) scan and cytology/biopsy studies,
which were longer in QDU2 patients, and in the waiting times to
ultrasonography, endoscopy, scintigraphy, and body fluoro-
deoxyglucose-positron emission tomography (FDG-PET), which
were longer in QDU1 patients.
Analyses according to patients’ age (<65 vs ≥65 years),
number of visits needed to make a diagnosis (2 vs>2), and final
diagnosis (malignancy vs no malignancy) in the 2 groups are
detailed in Tables 3–5. The most relevant statistically significant
results according to age are shown in Table 3. While QDU1
patients aged ≥65 years were less likely to have fever as a cause
for referral than those aged<65 years, older QDU2 patients were
more likely than younger patients to have UWL, adenopathies
and/or palpable masses and gastrointestinal symptoms but less
likely to have anemia. Moreover, QDU2 patients aged ≥65 years
were more likely than those aged <65 years to be males, to
undergo several examinations except endoscopy, which was
more commonly performed, albeit not significantly, among
younger patients, and to be referred onward to specialist
outpatient clinics. When comparing the 2 QDU groups according
to patients’ age, significant differences were observed in anemia
and gastrointestinal symptoms as referral reasons, number of
patients needing 2 visits, time-to-diagnosis, number of several
examinations, and onward referrals (Table 3).
Analysis according to the number of visits needed to make a
final diagnosis revealed that QDU1 patients with >2 visits were
more likely than those with 2 visits to have UWL and
adenopathies and/or palpable masses but less likely to have
anemia as referral reasons. While time-to-diagnosis was longer in
QDU1 patients needing >2 visits, these patients more commonly
underwent examinations than those needing 2 visits. Endosco-
py, however, was more frequently conducted in the latter yet
without statistical significance. Moreover, QDU1 patients with
>2 visits were more often referred after diagnosis to the reference
hospital specialist outpatient clinics. Similar results were
observed in QDU2 patients: patients needing >2 visits were
more likely than those needing 2 visits to have UWL,4
adenopathies, and/or palpable masses but less likely to have
anemia as referral reasons. Unlike QDU1 patients, however,
gastrointestinal symptoms were more frequent among QDU2
patients with >2 visits. Also, similar to the QDU1 group, QDU2
patients needing >2 visits had a longer time-to-diagnosis,
underwent examinations more frequently than those needing
2 visits with the exception of endoscopy, which was more often
performed in the latter, and were more commonly referred
onward to the hospital outpatient clinics. Comparative analysis
of the 2 groups according to the number of visits revealed
significant differences in gastrointestinal symptoms as referral
reason and in the waiting times to ultrasonography and
endoscopy (Table 4).
Lastly, themost remarkable significant differences according to
the final diagnosis are shown in Table 5. In particular, QDU1
patients with malignancy were older than those without it and
were more likely to have UWL and adenopathies and/or palpable
masses, to have a higher mean number of visits, to need less often
2 visits, to undergo more CT scans, body FDG-PETs and
cytology/biopsy studies, and to be referred onward to outpatient
clinics of the reference hospital. A similar pattern was seen in
QDU2 patients: patients with cancer were older and were more
likely to have UWL and adenopathies and/or palpable masses as
referral reasons. Although anemia was less frequent in both
QDU2 and 1 patient with cancer, statistical significance was not
reached in the latter. In addition, gastrointestinal symptoms as
referral reason were more common in QDU2 patients with
cancer. QDU2 patients with cancer were also more likely than
those without it to be males, to be initially referred from the ED,
and to undergo more examinations except endoscopy, which was
more commonly conducted, albeit without statistical significance,
in both QDU2 and 1 patient without cancer. Unlike QDU1
patients, however, time-to-diagnosis was longer in QDU2
patients with malignancy than in those without it. Moreover,
QDU2 patients with cancer were more commonly hospitalized
and were more often referred onward to the hospital outpatient
clinics, with only 1% being referred to PCCs. When comparing
the 2 QDU groups according to final diagnosis, statistically
significant differences were observed in the sources of referral,
gastrointestinal symptoms as referral reason, time-to-diagnosis,
number of patients undergoing ultrasonography and bone
marrow aspiration, and in the waiting time to body FDG-PET
(Table 5).4. Discussion
To the best of our knowledge, this is the first study to compare the
performance of 2 hospital-based QDUs. Despite some differ-
ences, our results show that, for diagnostic purposes, the overall
performance and effectiveness of QDUs of urban district and
reference general hospitals in evaluating patients with predefined
referral criteria and suspected serious conditions were similar.
Among the differences observed, the ED clearly surpassed
PCCs as referral source in QDU2. This may partly indicate that,
in contrast to PCCs, patients presenting to the ED of the reference
hospital can be directly referred to QDU2 without previous
checking by the physician in charge of this unit.[24,28] Although
PCC physicians are aware of the referral criteria to QDU2, some
patients do not meet these criteria and are instead referred to
other units as decided by the QDU2 physician when assessing the
PCC referral reports.[28] Considering the amount of PCC referral
reports to QDU2, without previous checking, the number of
patients referred to the unit would surpass the number referred
Table 3
Comparative analyses according to age.
QDU1 (N=336) a QDU2 (N=530) b
<65 y (n=161) ≥65 y (n=175) P value <65 y (n=267) ≥65 y (n=263) P value P value a vs b
Sex, n (%) .19 <.001 .33
Females 95 (59) 90 (51) 150 (56) 126 (48)
Males 66 (41) 85 (49) 117 (44) 137 (52)
Referral sources, n (%)
Primary care centers 119 (74) 114 (65) .10 93 (35) 82 (31) .09 .14
Emergency departments 27 (17) 3 (18) .93 153 (57) 160 (61) .10 .16
Hospital outpatient clinics 14 (9) 25 (14) .15 14 (5) 18 (7) .26 .19
Others 1 (1) 5 (3) .26 7 (3) 3 (1) .25 .09
Reasons for referral, n (%)
Unintentional weight loss 30 (19) 41 (23) .27 33 (12) 52 (20) <.001 .23
Adenopathies and/or palpable masses 13 (8) 19 (11) .37 22 (8) 36 (14) .04 .21
Anemia 16 (10) 30 (17) .08 72 (27) 39 (15) <.001 <.001
Fever 8 (5) 1 (1) .03 35 (13) 29 (11) .27 .22
Gastrointestinal symptoms 17 (11) 15 (9) .66 40 (15) 61 (23) <.001 .03
Test abnormalities 27 (17) 21 (12) .28 20 (7) 7 (3) .07 .17
Osteoarticular symptoms 9 (6) 12 (7) .80 7 (3) 4 (2) .31 .15
Unexplained tiredness 9 (6) 8 (5) .86 3 (1) 2 (1) .36 .18
Respiratory symptoms 6 (4) 2 (1) .23 19 (7) 13 (5) .27 .24
Neurological disorders 2 (1) 5 (3) .51 3 (1) 1 (0) .30 .10
Ascites 1 (1) 1 (1) .52 1 (0) 9 (3) .20 .08
Other 23 (14) 20 (11) .54 12 (4) 10 (4) .34 .20
Time to first visit (d), mean (SD) 6.19 (6.60) 9.35 (22.30) .13 3.82 (1.70) 4.13 (1.64) .10 .08
Number of visits, mean (SD) 2.14 (0.91) 2.10 (1.10) .72 3.2 (1.23) 3.6 (1.19) .06 .11
2 visits to achieve diagnosis, n (%) 116 (72) 130 (74) .71 156 (58) 145 (55) .16 .04
Time-to-diagnosis, mean (SD) 23.81 (37.74) 21.03 (30.08) .47 8.82 (4.03) 9.21 (4.00) .09 .03
Diagnostic examinations, n (%)
CT scan 5 (32) 44 (25) .23 71 (27) 99 (38) <.001 <.001
MRI 15 (9) 13 (7) .56 20 (7) 33 (13) .03 .02
Ultrasonography 17 (11) 11 (6) .17 31 (12) 49 (19) .01 .001
Endoscopy 13 (8) 24 (14) .12 50 (19) 40 (15) .12 .002
Scintigraphy 1 (1) 5 (3) .22 3 (1) 13 (5) .08 .26
Body FDG-PET 3 (2) 4 (2) .10 5 (2) 16 (6) .07 .11
Cytology/biopsy 16 (10) 16 (9) .85 43 (16) 68 (26) <.001 .04
Bone marrow aspiration 4 (2) 8 (5) .38 14 (5) 23 (9) .09 .24
Time to examination (d), mean (SD)
CT scan 3.24 (3.35) 3.27 (3.40) .96 4.10 (1.86) 3.90 (1.74) .13 .11
MRI 7.27 (7.10) 7.77 (7.87) .86 6.12 (3.35) 5.86 (3.20) .10 .09
Ultrasonography 5.35 (7.04) 6.00 (5.89) .81 3.65 (1.22) 2.89 (1.15) .07 .08
Endoscopy 22.60 (37.35) 20.06 (19.46) .82 6.42 (3.80) 5.63 (3.43) .06 .25
Scintigraphy 2 (na) 7.50 (4.20) .33 3.15 (1.17) 3.04 (1.08) .18 .07
Body FDG-PET 4.33 (4.93) 6.25 (2.36) .52 4.27 (2.06) 3.92 (1.87) .11 .08
Cytology/biopsy 6.08 (5.36) 2.79 (1.71) .04 5.70 (1.30) 4.95 (3.00) .08 .18
Bone marrow aspiration 4.33 (2.08) 2.50 (1.38) .15 2.85 (1.10) 2.27 (1.00) .09 .26
Referral upon discharge, n (%)
Primary care centers 72 (45) 68 (39) .33 169 (63) 149 (57) .04 .33
Hospital Plató outpatient clinics 63 (39) 79 (45) .32 na na na
Hospital Clínic outpatient clinics 16 (10) 12 (7) .41 84 (31) 102 (39) <.001 <.001
Others 2 (1) 8 (5) .14 3 (1) 4 (2) .30 .15
Admission 2 (1) 2 (1) .68 2 (1) 6 (2) .28 .26
Lost to follow-up 6 (4) 6 (3) .88 9 (3) 2 (1) .21 .29
Missing data: variable “time to first visit” (n=5 in QDU2 patients aged <65 y and n=4 in QDU2 patients aged ≥65 y).
CT= computed tomography, FDG-PET= fluorodeoxyglucose-positron emission, MRI=magnetic resonance imaging, na=not applicable, QDU1=quick diagnosis unit of Hospital Plató, QDU2=quick diagnosis
unit of Hospital Clínic, SD= standard deviation.
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sources of patients to the 2 units undoubtedly determine the
clinical reasons for referral,[24,28] the main causes did not differ
substantially, with some exceptions. In general, QDU2 patients
presented with more “urgent” conditions such as anemia (mostly
corresponding to severe microcytic anemia requiring transfu-
sion),[29,30] fever[27] and gastrointestinal symptoms including
rectorrhagia, dysphagia, and unexplained severe abdominal pain5
(data not shown) (Table 1). Conversely, QDU1 patients had a
higher frequency of less “urgent” or “severe” disorders than
QDU2 patients such as UWL, test abnormalities, osteoarticular
symptoms, and unexplained tiredness. These differences most
likely reflected the differences in the referral sources (Table 1).
A salient difference was observed in the time to first visit, which
was quicker in QDU2 than in QDU1. This could be explained
both by the direct appointments to QDU2 at ED and the
[24,28]
Table 4
Comparative analyses according to number of visits.
QDU1 (N=336) a QDU2 (N=530) b
2 visits (n=246) >2 visits (n=90) P value 2 visits (n=302) >2 visits (n=228) P value P value a vs b
Age, y, mean (SD) 62.19 (20.20) 61.36 (19.27) .73 60.17 (17.11) 60.85 (17.62) .19 .08
Sex, n (%) .18 .27 .10
Females 141 (57) 44 (49) 154 (51) 113 (50)
Males 105 (43) 46 (51) 148 (49) 115 (50)
Referral sources, n (%)
Primary care centers 173 (70) 60 (67) .61 106 (35) 69 (30) .06 .23
Emergency departments 39 (16) 19 (21) .33 174 (58) 139 (61) .13 .22
Hospital outpatient clinics 30 (12) 9 (10) .72 16 (5) 16 (7) .31 .07
Others 4 (2) 2 (2) .92 6 (2) 4 (2) .30 .38
Reasons for referral, n (%)
Unintentional weight loss 45 (18) 26 (29) .01 36 (12) 49 (21) <.001 .26
Adenopathies and/or palpable masses 20 (8) 12 (13) .04 24 (8) 34 (15) <.001 .25
Anemia 42 (17) 4 (4) .005 82 (27) 29 (13) <.001 .22
Fever 5 (2) 4 (4) .17 40 (13) 24 (11) .17 .09
Gastrointestinal symptoms 23 (14) 9 (10) .98 47 (16) 54 (24) <.001 .004
Test abnormalities 36 (15) 12 (13) .90 22 (7) 5 (2) .06 .28
Osteoarticular symptoms 17 (7) 4 (4) .57 7 (2) 4 (2) .29 .24
Unexplained tiredness 14 (6) 3 (3) .55 4 (1) 1 (0) .26 .26
Respiratory symptoms 8 (3) 0 (0) .18 20 (7) 12 (5) .20 .34
Neurological disorders 4 (2) 3 (3) .59 3 (1) 1 (0) .27 .14
Ascites 1 (0) 1 (1) .95 4 (1) 6 (3) .22 .30
Other 31 (13) 12 (13) .99 13 (4) 9 (4) .33 .35
Time to first visit (d), mean (SD) 8.77 (19.61) 5.64 (6.48) .18 3.93 (1.81) 4.16 (1.63) .16 .09
Time-to-diagnosis (d), mean (SD) 13.56 (20.71) 45.75 (48.38) <.001 7.80 (3.45) 9.61 (4.12) <.001 .06
Diagnostic examinations, n (%)
CT scan 53 (22) 42 (47) <.001 60 (20) 110 (48) <.001 .31
MRI 8 (3) 20 (22) <.001 16 (5) 37 (16) <.001 .16
Ultrasonography 14 (6) 14 (15) .007 32 (11) 48 (21) <.001 .28
Endoscopy 29 (12) 8 (9) .56 60 (20) 30 (13) <.001 .18
Scintigraphy 3 (1) 3 (3) .20 7 (2) 9 (4) .22 .33
Body FDG-PET 1 (0) 6 (7) .002 5 (2) 16 (7) .04 .26
Cytology/biopsy 13 (5) 19 (21) <.001 38 (13) 73 (32) <.001 .17
Bone marrow aspiration 4 (2) 8 (9) .004 11 (4) 26 (11) <.001 .37
Time to examination (d), mean (SD)
CT scan 3.08 (3.20) 3.48 (3.56) .73 3.87 (1.64) 4.31 (1.52) .10 .32
MRI 6.25 (6.92) 8.00 (7.60) .18 5.77 (2.66) 6.50 (2.50) .07 .22
Ultrasonography 8.38 (7.96) 3.00 (3.40) .02 2.76 (1.08) 3.24 (1.02) .11 .04
Endoscopy 25.44 (21.73) 5.40 (4.62) .06 5.92 (3.17) 6.18 (3.03) .13 .03
Scintigraphy 5.50 (4.95) 7.00 (5.00) .76 3.03 (1.24) 3.25 (1.15) .14 .14
Body FDG-PET 2.00 (na) 6.00 (3.41) .33 3.90 (1.76) 4.25 (1.58) .11 .12
Cytology/biopsy 4.00 (4.52) 4.59 (4.11) .73 4.56 (2.13) 5.80 (2.07) .005 .20
Bone marrow aspiration 4.00 (2.83) 2.86 (1.57) .46 2.20 (1.04) 2.86 (1.01) .08 .07
Referral upon discharge, n (%)
Primary care centers 112 (45) 28 (31) .02 200 (66) 118 (52) <.001 .33
Hospital Plató outpatient clinics 97 (39) 45 (50) .11 na na na
Hospital Clínic outpatient clinics 13 (5) 15 (17) .002 84 (28) 102 (45) <.001 .26
Others 9 (4) 1 (1) .39 3 (1) 4 (2) .28 .11
Admission 4 (2) 0 (0) .52 7 (2) 1 (0) .23 .32
Lost to follow-up 11 (4) 1 (1) .26 8 (3) 3 (1) .25 .27
Missing data: variable “time to first visit” (n=6 in QDU2 patients with 2 visits and n=3 in QDU2 patients with >2 visits).
CT= computed tomography, FDG-PET= fluorodeoxyglucose-positron emission, MRI=magnetic resonance imaging, na=not applicable, QDU1=quick diagnosis unit of Hospital Plató, QDU2=quick diagnosis
unit of Hospital Clínic, SD= standard deviation.
Montori-Palacín et al. Medicine (2017) 96:22 Medicineadministrative support of the unit. Furthermore, although
patients evaluated in QDU1 required less visits to be diagnosed,
the time-to-diagnosis was significantly longer than in QDU2, a
finding related to the unavailability of administrative staff in the
former (see below). Although the frequency of cancer as a final
diagnosis in the 2 units is consistent with former
reports,[21,22,24,26,31] its significantly higher occurrence in
QDU2 than in QDU1 patients is mostly justified by the
considerably higher rate of digestive malignancies (mainly6
colorectal and pancreatic cancer) among patients presenting
with gastrointestinal symptoms (24% in QDU2 vs 2% in QDU1)
(data not shown).
It is of note that QDU activity and reasons for referral
according to patients’ age, number of visits, and final diagnosis
have not been analyzed previously. Patients from the 2 groups
with cancer shared several characteristics: they were older and
more often (P not significant in QDU1) males than those without
cancer, had more commonly UWL and adenopathies and/or
Table 5
Comparative analyses according to final diagnosis.











Age, y, mean (SD) 61.14 (20.30) 67.51 (17.20) .04 59.75 (17.77) 64.94 (16.58) <.001 .29
≥65 y, n (%) 142 (51) 27 (60) 205 (49) 58 (57)
<65 y, n (%) 137 (49) 18 (40) 214 (51) 43 (43)
Sex, n (%) .42 <.001 .18
Females 157 (56) 22 (49) 226 (54) 45 (45)
Males 122 (44) 23 (51) 193 (46) 56 (55)
Referral sources, n (%)
Primary care centers 197 (71) 27 (60) .21 141 (34) 30 (30) .09 .16
Emergency departments 48 (17) 7 (16) .95 246 (59) 65 (64) .04 .04
Hospital outpatient clinics 30 (11) 9 (20) .13 24 (6) 5 (5) .24 .02
Others 4 (1) 2 (4) .43 8 (2) 1 (1) .25 .06
Reasons for referral, n (%)
Unintentional weight loss 48 (17) 23 (51) <.001 53 (13) 27 (27) <.001 .18
Adenopathies and/or palpable masses 22 (8) 10 (22) <.001 38 (9) 16 (16) <.001 .24
Anemia 40 (14) 3 (7) .24 103 (25) 8 (8) <.001 .29
Fever 7 (3) 2 (5) .81 54 (13) 10 (10) .23 .08
Gastrointestinal symptoms 29 (10) 1 (2) .14 76 (18) 24 (24) .03 .001
Test abnormalities 44 (15) 3 (7) .17 24 (6) 3 (3) .17 .13
Osteoarticular symptoms 21 (8) 0 (0) .11 10 (2) 1 (1) .23 .11
Unexplained tiredness 17 (6) 0 (0) .18 5 (1) 0 (0) .26 .12
Respiratory symptoms 8 (3) 0 (0) .53 29 (7) 3 (3) .08 .34
Neurological disorders 7 (3) 0 (0) .60 4 (1) 0 (0) .28 .27
Ascites 1 (0) 1 (2) .65 4 (1) 6 (6) .06 .18
Other 37 (13) 3 (7) .32 19 (5) 3 (3) .18 .26
Time to first visit (d), mean (SD) 8.35 (18.27) 5.95 (9.72) .43 3.73 (2.05) 4.25 (1.70) .06 .08
Number of visits, mean (SD) 2.05 (0.90) 2.71 (1.37) <.001 2.8 (1.18) 4.0 (1.62) <.001 .35
2 visits to achieve diagnosis, n (%) 209 (75) 26 (58) .02 251 (60) 51 (50) <.001 .29
Time-to-diagnosis, mean (SD) 23.32 (35.93) 16.60 (16.89) .22 7.92 (3.62) 9.71 (4.53) <.001 .02
Diagnostic examinations, n (%)
CT scan 59 (21) 31 (69) <.001 85 (20) 85 (84) <.001 .32
MRI 22 (8) 6 (13) .25 13 (3) 40 (40) <.001 .14
Ultrasonography 25 (9) 1 (2) .15 30 (7) 50 (50) <.001 <.001
Endoscopy 30 (11) 4 (9) 1 76 (18) 14 (14) .09 .26
Scintigraphy 4 (1) 4 (4) .20 6 (1) 10 (10) <.001 .17
Body FDG-PET 2 (1) 5 (11) .001 3 (1) 18 (18) <.001 .15
Cytology/biopsy 11 (4) 21 (47) <.001 31 (7) 80 (79) <.001 .17
Bone marrow aspiration 10 (4) 2 (4) .68 9 (2) 28 (28) <.001 .03
Time to examination (d), mean (SD)
CT scan 3.61 (3.36) 2.35 (2.56) .07 4.21 (2.06) 3.76 (1.43) .10 .21
MRI 8.82 (7.69) 2.67 (2.34) .06 6.42 (3.40) 5.53 (2.82) .06 .14
Ultrasonography 5.29 (5.71) 0.00 (na) .37 3.36 (1.54) 2.64 (1.20) .07 .11
Endoscopy 21.06 (22.50) 12.67 (8.33) .54 6.67 (4.15) 5.42 (3.19) .004 .10
Scintigraphy 9.33 (2.52) 2.00 (0.00) .03 3.30 (1.48) 3.00 (1.04) .12 .12
Body FDG-PET 2.50 (0.71) 6.60 (3.43) .17 4.48 (2.30) 3.71 (1.40) .06 .03
Cytology/biopsy 5.57 (5.53) 3.95 (3.69) .39 5.31 (2.84) 5.04 (2.57) .13 .23
Bone marrow aspiration 3.38 (1.69) 1.00 (na) .23 3.00 (1.39) 2.07 (1.04) .04 .16
Referral upon discharge, n (%)
Primary care centers 140 (50) 0 (0) <.001 317 (76) 1 (1) <.001 .34
Hospital Plató outpatient clinics 118 (42) 24 (53) .33 na na na
Hospital Clínic outpatient clinics 11 (4) 17 (38) <.001 94 (22) 92 (91) <.001 .37
Others 8 (3) 2 (4) .92 6 (1) 1 (2) .27 .39
Admission 2 (1) 2 (4) .17 2 (0) 6 (6) .04 .18
Lost to follow-up 10 (4) 2 (4) .98 10 (2) 1 (1) .24 .29
Missing data: variable “time to first visit” (n=7 in QDU2 patients with no malignancy and n=2 in QDU2 patients with malignancy).
CT= computed tomography, FDG-PET= fluorodeoxyglucose-positron emission, MRI=magnetic resonance imaging, na=not applicable, QDU1=quick diagnosis unit of Hospital Plató, QDU2=quick diagnosis
unit of Hospital Clínic, SD= standard deviation.
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anemia, and underwent more examinations except endoscopies,
which were less frequently conducted, yet without significance, in
patients from the 2 groups. However, while time-to-diagnosis7
was nonsignificantly shorter in QDU1 patients with cancer than
in those without it, it was significantly longer in QDU2 patients
with cancer. The longer waiting times to some diagnostic tests in
QDU2 compared with QDU1 patients with cancer explicate this
Montori-Palacín et al. Medicine (2017) 96:22 Medicinedifference (e.g., 5.04 vs 3.95 days to cytology/biopsy studies,
respectively, or 3.76 vs 2.35 days to CT scan, respectively)
(Table 5). With regard to QDU activity and referral reasons
according to patients’ age, the 2 groups also shared some
features: patients aged ≥65 years were more likely than younger
patients to be males (nonsignificantly in QDU1), to have
(nonsignificantly in QDU1) UWL and adenopathies and/or
palpable masses but less likely (nonsignificantly in QDU2) fever,
and to be referred onward to outpatient clinics (nonsignificantly
in QDU1). A similar pattern was observed when considering the
QDU performance and reasons for referral according to the
number of visits. Briefly, similar to patients with a diagnosis of
malignancy, patients needing>2 visits were more often, although
nonsignificantly, males, had more commonly UWL and adeno-
pathies and/or palpable masses but less commonly anemia as
referral reasons, and underwent more examinations than those
needing 2 visits except endoscopies, which were more
frequently conducted in the latter (nonsignificantly in QDU1).
Also, patients with >2 visits were more often referred onward to
outpatient clinics, while those with 2 visits were more
commonly referred to PCCs.
Although several characteristics of the functioning and
outcomes of QDU1 and the patients evaluated at it are not
substantially different from those reported in other
QDUs,[19,24,26,31] a key difference lies in the resources the
unit at the district hospital has. While the unit of the reference
hospital has an attending physician full-time and administra-
tive and nursing staff to arrange appointments and deliver
healthcare nursing work, respectively,[24] QDU1 has an
attending physician part-time but neither administrative nor
nursing staff of its own. Nevertheless, whereas the amount of
patients evaluated at the reference center unit is considerably
greater and justifies a full team of healthcare and administra-
tive professionals, an unreported pilot study concluded that
the number of patients evaluated at QDU1 was proportional to
the part-time work of the physician in charge of it. Yet, the
unavailability of administrative personnel poses obvious
organization problems for several actions, most notably
appointments, with potential negative consequences in achiev-
ing, among other things, proper timings including quicker
times from referral to first visit and quicker times to diagnosis.
It is of note that the QDU1 attending physician herself
undertakes most of the administrative work.
Comparing the QDU of a urban district hospital with the
unit of a general hospital, which is in addition the reference
center of the former, yielded some interesting findings.
Because the former is a small hospital with a smaller reference
population, some diagnostic tests ordered by the QDU
physician (e.g., CT scans and cytology/biopsy studies
(Table 2)) were performed in fairly short times—even faster
than the same tests ordered by the physician in charge of the
QDU of the reference hospital. A similar observation was
reported in the QDU of the smaller community Hospital of
Granollers.[26] The pattern of onward referrals is also a
distinctive feature. Unlike tertiary hospitals with their
outpatient clinics run by physicians from a broad range of
specialties, smaller hospitals commonly refer patients with
specific conditions other than prevalent chronic diseases to
those specialists at reference centers, predominantly for
treatment purposes. Indeed, a significant number of patients
diagnosed with serious conditions at QDU1 (e.g., 38% with
cancer) were referred onward to specialist outpatient clinics of
the reference hospital, mainly oncology clinics (Table 5).8
4.1. Limitations
While the design of the study allowed us to analyze homogeneous
variables including clinical and QDU variables, it should be read
in the context of its limitations. First, despite the prospective
assessment of QDU1 patients, the sample size was relatively
small. Second, some relevant data from the QDU2 group might
not have been fully captured—an inherent limitation linked to its
retrospective analysis. The exclusion of QDU1 and 2 patients lost
to follow-up together with QDU2 missing data could potentially
introduce bias to the results and subsequent conclusions.
Nevertheless, since only 23 patients were lost to follow-up and
there were minimal missing data on the variable “time to first
visit” the results were unlikely to be affected. Third, the handling
of patients referred to hospital-based outpatient clinics such as
those reported here or hospitalized for evaluating similar
conditions can be different in other clinical settings, a situation
relying on factors such as the institution traditions, the available
resources, or the type of center. Consequently, the findings and
potential implications of this study cannot be generalized. Last, a
matched-pair binary logistic regression model where QDU1 cases
were matched for age, sex, and time period with QDU2 cases at a
ratio of 1:2 and “differences in diagnosis” were taken as the
dependent variable (1=malignancy; 0=no malignancy) for each
matched pair against the predictors of “reasons for referrals” and
“diagnostic examinations”would likely provide a more powerful
measure of the effectiveness of QDU1 and 2. Although matching
was indeed done, the resulting sample was too small to perform a
logistic analysis (data not shown).
5. Conclusion and implications
Although studies on QDUs are scarce, these units have
proliferated exponentially both in general tertiary and smaller
community hospitals, predominantly in Spain, over the last 15
years. Reported studies include descriptive, single-center stud-
ies[26,31,32] and studies comparing QDUs with traditional
admission for workup.[22–27] Overall, results from these studies
conclude that the 2 settings are similarly operative in reaching a
timely diagnosis but that QDU savings from hospitalization are
striking. Our study adds evidence to the convenience of QDUs in
urban district hospital centers for diagnostic purposes and shows
that the similarities of the unit to the unit of the general hospital
outweigh the differences between them. Taken together, previous
and current data could lead to a thoughtful project intended to
create guidelines for a standardized infrastructure and function-
ing of QDUs, most likely adjusted to the type of hospital and its
resources. While an economic evaluation of QDU1 and how it
compares to QDU2 should be explored next, the favorable
economic impact of these units with the cost-avoidance of
hospitalization may encourage the establishment of uniformly
operativeQDUs nationwide to ultimately improve their efficiency
as well as the efficiency of the national health service.
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